599605 Disclosed is the use of a composition comprising biocompatible poly-?-1(4-N-acetylglucosamine in the manufacture of a medicament for treating a chronic wound in a human subject by repeated topical application of the composition every 5 to 18 days to a chronic wound in a human subject in need thereof.